EMA’s medical literature monitoring enters into full operation

The European Medicines Agency (EMA) starts its full medical literature monitoring service on 1 September 2015.

A total of 400 active substance groups (300 chemical active substance groups and 100 herbal active substance groups) will now be monitored by EMA. The service will benefit over 4,000 companies. The list of active substance groups and a reference to the journals covered by EMA’s medical literature monitoring service are available on the monitoring of medical literature page.  

Original source


Register for receiving PharmaAround news, register for PharmAround events.
Continue registration